What if we could predict breast cancer? Through plasma analysis, scientists have your odds – with 82% accuracy, years before disease onset.
The INTERCEPT Blood System for plasma: an innovative safety net for medicine, a preemptive strike against new outbreaks.
Convalescent plasma therapy could be an effective treatment to fight against the Ebola virus
The Ebola virus causes a serious and deadly disease transmitted by animals and humans. The current Ebola epidemic is the largest outbreak in history, affecting many countries in West Africa. The Ebola virus likely originated in African fruit bats, but apart from zoonotic transmission it can also be transmitted from one human to another via direct contact such as through broken skin or mucous membranes, bodily secretions or fluids, or by contact with surfaces and materials (e.g. bedding, clothing) contaminated with these fluids. So far, no FDA-approved vaccine or medicine is available to treat Ebola infection. Only a few primary prevention measures are available which are largely based on symptomatic treatment and by avoiding direct contact with infected people and animals.
Acquiring DNA from plasma may avoid problems with safety and bias. In terms of sequencing, recent work has helped make this approach a reality.
Standard apheresis equipment is soon to be supplanted. What are the advantages in the next generation?